William B. Capra

1.8k total citations · 1 hit paper
20 papers, 1.0k citations indexed

About

William B. Capra is a scholar working on Statistics and Probability, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, William B. Capra has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Statistics and Probability, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in William B. Capra's work include Statistical Methods in Clinical Trials (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Genomics and Diagnostics (4 papers). William B. Capra is often cited by papers focused on Statistical Methods in Clinical Trials (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Genomics and Diagnostics (4 papers). William B. Capra collaborates with scholars based in United States, Switzerland and Japan. William B. Capra's co-authors include Brandon Arnieri, Hans‐Georg Müller, Michael D. Taylor, Samuel Whipple, Gillis Carrigan, Michael W. Lu, Sandra D. Griffith, Ryan Copping, Aracelis Z. Torres and Paul You and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

William B. Capra

20 papers receiving 980 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluating eligibility criteria of oncology trials using real-world data and AI

2021 184 citations Ruishan Liu, Shemra Rizzo et al. Nature profile →

Peers

William B. Capra

ONCOL

PRM

VIROL

James Y. Dai United States

Weili He United States

Thomas Gsponer Switzerland

Holly Gundacker United States

Blythe Adamson United States

Kelong Han United States

Massimo Attanasio Italy

Aïcha Goubar France

Victoria Wang United States

Laurent Roche France

James Y. Dai United States

William B. Capra

99 ×0.4

ONCOL

213 ×1.0

85 ×0.4

PRM

110 ×0.6

VIROL

27 ×0.2

Citations per year, relative to William B. Capra William B. Capra (= 1×) peers James Y. Dai

Countries citing papers authored by William B. Capra

Since Specialization

Citations

This map shows the geographic impact of William B. Capra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William B. Capra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William B. Capra more than expected).

Fields of papers citing papers by William B. Capra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William B. Capra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William B. Capra. The network helps show where William B. Capra may publish in the future.

Co-authorship network of co-authors of William B. Capra

This figure shows the co-authorship network connecting the top 25 collaborators of William B. Capra. A scholar is included among the top collaborators of William B. Capra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William B. Capra. William B. Capra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Curtis, Melissa D., Shrujal S. Baxi, William B. Capra, et al.. (2022). Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations. Contemporary Clinical Trials Communications. 30. 101000–101000. 10 indexed citations

Carrigan, Gillis, Brian D. Bradbury, M. Alan Brookhart, et al.. (2022). External Comparator Groups Derived from Real-world Data Used in Support of Regulatory Decision Making: Use Cases and Challenges. Current Epidemiology Reports. 9(4). 326–337. 10 indexed citations

Liu, Ruishan, Shemra Rizzo, Samuel Whipple, et al.. (2021). Evaluating eligibility criteria of oncology trials using real-world data and AI. Nature. 592(7855). 629–633. 184 indexed citations breakdown →

Tucker, Melisa, et al.. (2021). Emulating Control Arms for Cancer Clinical Trials Using External Cohorts Created From Electronic Health Record‐Derived Real‐World Data. Clinical Pharmacology & Therapeutics. 111(1). 168–178. 19 indexed citations

Carrigan, Gillis, Samuel Whipple, William B. Capra, et al.. (2019). Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proof‐of‐Concept in Randomized Controlled Trials. Clinical Pharmacology & Therapeutics. 107(2). 369–377. 72 indexed citations

Carrigan, Gillis, Samuel Whipple, Michael D. Taylor, et al.. (2019). An evaluation of the impact of missing deaths on overall survival analyses of advanced non–small cell lung cancer patients conducted in an electronic health records database. Pharmacoepidemiology and Drug Safety. 28(5). 572–581. 43 indexed citations

Griffith, Sandra D., Rebecca A. Miksad, Paul You, et al.. (2019). Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set. JCO Clinical Cancer Informatics. 3(3). 1–13. 76 indexed citations

Barlési, Fabrice, Luis Paz‐Ares, Damian R. Page, et al.. (2018). P1.01-04 Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients. Journal of Thoracic Oncology. 13(10). S459–S460. 1 indexed citations

Curtis, Melissa D., Sandra D. Griffith, Melisa Tucker, et al.. (2018). Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint. Health Services Research. 53(6). 4460–4476. 166 indexed citations

10.

Shewade, Ashwini, Peter Lambert, Brandon Arnieri, et al.. (2017). Characteristics of advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving molecular diagnostic (MD) testing in U.S. routine clinical practice.. Journal of Clinical Oncology. 35(15_suppl). e20627–e20627. 1 indexed citations

11.

Iacono, Aldo, William B. Capra, Stephen B. Shrewsbury, et al.. (2005). Long-term follow up of a double-blind, randomized, placebo-controlled trial of Cyclosporine Inhalation Solution (CyIS) in lung transplant recipients. The Journal of Heart and Lung Transplantation. 24(2). S82–S83. 1 indexed citations

12.

Weng, David, Susan F. Radka, Ram Ganapathi, et al.. (2005). A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors. Molecular Cancer Therapeutics. 4(6). 948–955. 52 indexed citations

13.

Capra, William B.. (2004). Comparing the power of the discontinuation design to that of the classic randomized design on time-to-event endpoints. Controlled Clinical Trials. 25(2). 168–177. 14 indexed citations

14.

Emery, Sean, William B. Capra, David A. Cooper, et al.. (2000). Pooled Analysis of 3 Randomized, Controlled Trials of Interleukin‐2 Therapy in Adult Human Immunodeficiency Virus Type 1 Disease. The Journal of Infectious Diseases. 182(2). 428–434. 86 indexed citations

15.

Davey, Richard T., Robert L. Murphy, Francesco Graziano, et al.. (2000). Immunologic and Virologic Effects of Subcutaneous Interleukin 2 in Combination With Antiretroviral Therapy. JAMA. 284(2). 183–183. 138 indexed citations

16.

Davey, Richard T. & William B. Capra. (2000). Viral load in treatment with antiretroviral therapy and interleukin 2. PubMed. 284(16). 2055–6. 3 indexed citations

17.

Wang, Jane-Ling, Hans‐Georg Müller, & William B. Capra. (1998). Analysis of oldest-old mortality: lifetables revisited. The Annals of Statistics. 26(1). 42 indexed citations

18.

Capra, William B. & Hans‐Georg Müller. (1997). An Accelerated-Time Model for Response Curves. Journal of the American Statistical Association. 92(437). 72–83. 33 indexed citations

19.

Capra, William B. & Hans‐Georg Müller. (1997). An Accelerated-Time Model for Response Curves. Journal of the American Statistical Association. 92(437). 72–72. 6 indexed citations

20.

Wang, Jane-Ling, et al.. (1997). Early mortality surge in protein-deprived females causes reversal of sex differential of life expectancy in Mediterranean fruit flies. Proceedings of the National Academy of Sciences. 94(6). 2762–2765. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact